RICHARD 

 

ALDRICH 

DIRECTOR

LONGWOOD FOUNDERS FUND, L.P.   |  VERASTEM, INC.   |  OVASCIENCE, INC.   |  PTC THERAPEUTICS, INC.   |  MITOKYNE, INC.   |  COLORESCIENCE INC

SAKAE 

 

ASANUMA 

DIRECTOR

MITOKYNE, INC.   |  POTENZA THERAPEUTICS, INC.   |  AXIAL BIOTHERAPEUTICS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  DREN BIO, INC.   |  AXIAL THERAPEUTICS, INC.   |  NORMUNITY HOLDING COMPANY, LLC   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  CROSSBOW THERAPEUTICS, INC.

DAVID 

 

CORDO 

EXECUTIVE OFFICER

METAMARK GENETICS, INC.   |  MITOKYNE, INC.   |  POTENZA THERAPEUTICS, INC.   |  VESUVIUS PHARMACEUTICALS, INC.   |  TRIEZA THERAPEUTICS, INC.   |  RIBON THERAPEUTICS, INC.   |  ALLY THERAPEUTICS, INC.   |  WEREWOLF THERAPEUTICS, INC.

ANSBERT 

 

GADICKE 

DIRECTOR

ELIXIR PHARMACEUTICALS, INC.   |  CERIMON PHARMACEUTICALS, INC.   |  MPM BIOVENTURES V, L.P.   |  VERASTEM, INC.   |  ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC   |  MITOKYNE, INC.   |  CLINICAL INK, INC.   |  VIRACYTE, INC.   |  ALLOVIR, INC.   |  MPM ONCOLOGY INNOVATIONS FUND LP   |  ITEOS THERAPEUTICS, INC.   |  ONCOLOGY IMPACT FUND 2, L.P.   |  ORNA THERAPEUTICS HOLDINGS, LLC   |  NEXTPOINT THERAPEUTICS, INC.   |  MPM BIOVENTURES 2022, L.P.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.

KAZUMI 

 

SHIOSAKI 

EXECUTIVE OFFICER, DIRECTOR

COSTIM PHARMACEUTICALS INC.   |  SIDERIS PHARMACEUTICALS, INC.   |  MITOKYNE, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  REDONA THERAPEUTICS, INC.